TipRanks
pc:med72

Mediar Therapeutics

201 Brookline Ave Suite 1002 (10th floor) Boston, Massachusetts 02215, US
https://www.mediartx.com/
Mediar Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies designed to halt fibrosis by targeting the myofibroblast, the key pathogenic cell driving scarring and organ failure. The company advances antibody therapeutics across multiple organ systems with programs in systemic sclerosis, idiopathic pulmonary fibrosis, and chronic kidney disease.

Leadership & Board

Current Number of Employees59
Current LinkedIn Followers5,730

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$76M
Total Amount Raised$76M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$76M
Latest Funding Amount$76M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Company Momentum Positive

Articles Published on TipRanks2
Articles Published on TipRanks
2
LinkedIn Trend+0.54% followers
LinkedIn Trend
+0.54% followers
Workforce Trend+0.0% employees
Workforce Trend
+0.0% employees
Mediar Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Employee Trend

Mediar Therapeutics had 59 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
59Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Mediar Therapeutics had 5,730 followers as of October 5, 2026. The number of followers increased by 31 (0.54%) week-over-week.
5,730Latest Followers Count
31(0.54%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2026
Series B
$76.00M
―

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Mediar Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis